FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140167424> ?p ?o ?g. }

• W2140167424 endingPage "147" @default.
• W2140167424 startingPage "137" @default.
• W2140167424 abstract "The successful development of an RSV vaccine requires a better understanding of the pathogenesis of primary infection, susceptibility to reinfection, and the immunopathology of enhanced illness in children immunized with a non-replicating RSV candidate vaccine. The exact role of different immune parameters in RSV pathogenesis remains controversial.To study the contribution of antibodies directed to the linear antigenic and immunogenic regions of the N and P proteins in the titer rise and avidity maturation of total anti-RSV antibodies.The occurrence of antibodies directed against three linear antigenic and immunogenic regions in each of the nucleocapsid (N): N3 (Thr11 to Gly30), N25 (Ser231 to Ala250) and N39 (Thr371 to Leu391), and the phospho-(P) proteins of respiratory syncytial virus (RSV), subgroup A: P49 (Pro91 to Asp110), P56 (Ser161 to Lys180) and P62 (Glu221 to Phe241), were analyzed in ELISA with (a) 32 paired sera from humans with recent or previous RSV subgroup A and/or B infection diagnosed by conventional ELISA, detection of antigen in nasopharyngeal aspirates and measurement of antibody avidity change; and (b) 40 RSV antibody-positive sera (HCS) obtained from patients during their convalescence from RSV infection and possessing clearly demonstrable titers of RSV IgG in conventional enzyme immunoassays (EIA) based on whole RSV antigen.The titer rise of antibodies directed to the combined three peptides representing the RSV N protein was well correlated with the rise in anti-RSV antibodies measured in whole antigen ELISA. Surprisingly, the rise in antibodies against a truncated main C-terminal epitope (Gln381 to Leu391) of the N protein (represented by subgroup A specific sequence of the N39/1 peptide) was inversely correlated with the titer rise of total anti-RSV antibodies. The titer rise of antibodies to the C-terminal linear site of the RSV N (N39/1) protein was subgroup-specific during the course of primary RSV infection. A titer rise in antibodies to the C-terminal linear sites of RSV N (i.e. N39/1) and P (P62) proteins had a dominating appearance in sera from newborn infants (6-7 months) and from patients with RSV reinfections. Anti-RSV antibody titers of late convalescent sera correlated with the titers of antibodies directed to the C-terminal linear site of RSV P (P62) protein. The avidity maturation of the anti-RSV immune response followed the titer rise of anti-P62 antibodies during the course of primary or secondary RSV infection." @default.
• W2140167424 created "2016-06-24" @default.
• W2140167424 creator A5008031344 @default.
• W2140167424 creator A5010862669 @default.
• W2140167424 creator A5020494867 @default.
• W2140167424 creator A5027397022 @default.
• W2140167424 creator A5031136559 @default.
• W2140167424 creator A5038432833 @default.
• W2140167424 date "1998-08-01" @default.
• W2140167424 modified "2023-10-01" @default.
• W2140167424 title "Development of human antibodies against linear antigenic and immunogenic regions of respiratory syncytial virus (RSV) nucleocapsid and phospho-proteins shows the site-directed characteristics" @default.
• W2140167424 cites W1497413965 @default.
• W2140167424 cites W1511209971 @default.
• W2140167424 cites W1534531493 @default.
• W2140167424 cites W1551043459 @default.
• W2140167424 cites W1572013878 @default.
• W2140167424 cites W1966592347 @default.
• W2140167424 cites W1968605303 @default.
• W2140167424 cites W1968964277 @default.
• W2140167424 cites W1974542809 @default.
• W2140167424 cites W2006383734 @default.
• W2140167424 cites W2046013402 @default.
• W2140167424 cites W2046367838 @default.
• W2140167424 cites W2051029022 @default.
• W2140167424 cites W2053288132 @default.
• W2140167424 cites W2062745357 @default.
• W2140167424 cites W2081114699 @default.
• W2140167424 cites W2082846444 @default.
• W2140167424 cites W2094954825 @default.
• W2140167424 cites W2104427618 @default.
• W2140167424 cites W2104639369 @default.
• W2140167424 cites W2125164095 @default.
• W2140167424 cites W2127921602 @default.
• W2140167424 cites W2129209209 @default.
• W2140167424 cites W2129441553 @default.
• W2140167424 cites W2143572217 @default.
• W2140167424 cites W2163307269 @default.
• W2140167424 cites W4206610548 @default.
• W2140167424 doi "https://doi.org/10.1016/s1386-6532(98)00045-2" @default.
• W2140167424 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9785215" @default.
• W2140167424 hasPublicationYear "1998" @default.
• W2140167424 type Work @default.
• W2140167424 sameAs 2140167424 @default.
• W2140167424 citedByCount "4" @default.
• W2140167424 countsByYear W21401674242014 @default.
• W2140167424 countsByYear W21401674242018 @default.
• W2140167424 crossrefType "journal-article" @default.
• W2140167424 hasAuthorship W2140167424A5008031344 @default.
• W2140167424 hasAuthorship W2140167424A5010862669 @default.
• W2140167424 hasAuthorship W2140167424A5020494867 @default.
• W2140167424 hasAuthorship W2140167424A5027397022 @default.
• W2140167424 hasAuthorship W2140167424A5031136559 @default.
• W2140167424 hasAuthorship W2140167424A5038432833 @default.
• W2140167424 hasConcept C141071460 @default.
• W2140167424 hasConcept C147483822 @default.
• W2140167424 hasConcept C159047783 @default.
• W2140167424 hasConcept C159654299 @default.
• W2140167424 hasConcept C179223381 @default.
• W2140167424 hasConcept C180915046 @default.
• W2140167424 hasConcept C195616568 @default.
• W2140167424 hasConcept C203014093 @default.
• W2140167424 hasConcept C22889606 @default.
• W2140167424 hasConcept C2522874641 @default.
• W2140167424 hasConcept C2777546802 @default.
• W2140167424 hasConcept C2777945365 @default.
• W2140167424 hasConcept C2780942790 @default.
• W2140167424 hasConcept C32611913 @default.
• W2140167424 hasConcept C71924100 @default.
• W2140167424 hasConcept C7842527 @default.
• W2140167424 hasConcept C86803240 @default.
• W2140167424 hasConcept C8891405 @default.
• W2140167424 hasConceptScore W2140167424C141071460 @default.
• W2140167424 hasConceptScore W2140167424C147483822 @default.
• W2140167424 hasConceptScore W2140167424C159047783 @default.
• W2140167424 hasConceptScore W2140167424C159654299 @default.
• W2140167424 hasConceptScore W2140167424C179223381 @default.
• W2140167424 hasConceptScore W2140167424C180915046 @default.
• W2140167424 hasConceptScore W2140167424C195616568 @default.
• W2140167424 hasConceptScore W2140167424C203014093 @default.
• W2140167424 hasConceptScore W2140167424C22889606 @default.
• W2140167424 hasConceptScore W2140167424C2522874641 @default.
• W2140167424 hasConceptScore W2140167424C2777546802 @default.
• W2140167424 hasConceptScore W2140167424C2777945365 @default.
• W2140167424 hasConceptScore W2140167424C2780942790 @default.
• W2140167424 hasConceptScore W2140167424C32611913 @default.
• W2140167424 hasConceptScore W2140167424C71924100 @default.
• W2140167424 hasConceptScore W2140167424C7842527 @default.
• W2140167424 hasConceptScore W2140167424C86803240 @default.
• W2140167424 hasConceptScore W2140167424C8891405 @default.
• W2140167424 hasIssue "2" @default.
• W2140167424 hasLocation W21401674241 @default.
• W2140167424 hasLocation W21401674242 @default.
• W2140167424 hasOpenAccess W2140167424 @default.
• W2140167424 hasPrimaryLocation W21401674241 @default.
• W2140167424 hasRelatedWork W1655785034 @default.
• W2140167424 hasRelatedWork W1966248592 @default.
• W2140167424 hasRelatedWork W2012280098 @default.
• W2140167424 hasRelatedWork W2013491202 @default.

• next